Linear triazole‐linked pseudo oligogalactosides as scaffolds for galectin inhibitor development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Linear triazole‐linked pseudo oligogalactosides as scaffolds for galectin inhibitor development

Published:2020-10 Issue:4 Volume:96 Page:1123-1133
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Dussouy Christophe¹,Kishor Chandan²^ORCID,Lambert Annie¹,Lamoureux Clément¹,Blanchard Helen²³^ORCID,Grandjean Cyrille¹^ORCID

Affiliation:

1. Unité Fonctionnalité et Ingénierie des Protéines (UFIP) CNRS, UMR 6286 Université de Nantes Nantes France

2. Institute for Glycomics Griffith University Gold Coast QLD Australia

3. School of Chemistry and Molecular Bioscience, and Molecular Horizons University of Wollongong Wollongong NSW Australia

Funder

Servier

Australian Synchrotron

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13683

Reference48 articles.

1. Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells

2. Combining glycocluster synthesis with protein engineering: an approach to probe into the significance of linker length in a tandem-repeat-type lectin (galectin-4)

3. Biophysical and structural characterization of mono/di-arylated lactosamine derivatives interaction with human galectin-3

4. Phenylenediamine catalysis of “click glycosylations” in water: practical and direct access to unprotected neoglycoconjugates

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Mechanism and Key Active Ingredients of Shenfu Injection in Sepsis: A Network Pharmacology and Molecular Docking Approach;Evidence-Based Complementary and Alternative Medicine;2022-08-26

2. Investigation of the Molecular Details of the Interactions of Selenoglycosides and Human Galectin-3;International Journal of Molecular Sciences;2022-02-24

3. Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors;RSC Advances;2022

4. Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19;Biomedicines;2021-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3